CRISPR Therapeutics
CRSP
#3304
Rank
A$5.27 B
Marketcap
$61.11
Share price
1.48%
Change (1 day)
-28.66%
Change (1 year)

Earnings for CRISPR Therapeutics (CRSP)

Earnings in 2024 (TTM): -A$0.55 Billion

According to CRISPR Therapeutics's latest financial reports the company's current earnings are A$35 Million. a decrease over its 2023 earnings that were of -A$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CRISPR Therapeutics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 -A$0.57 Billion140.62%
2023 -A$0.24 Billion-76.83%
2022 -A$1.02 Billion-271.4%
2021 A$0.59 B-209.04%
2020 -A$0.55 Billion-617.12%
2019 A$0.10 B-140.93%
2018 -A$0.26 Billion146.86%
2017 -A$0.11 Billion193.19%
2016 -A$35.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.23 Billion-60.60%๐Ÿ‡บ๐Ÿ‡ธ USA